Serotonin releasers increase prepulse inhibition in serotonin 1B knockout mice

Psychopharmacology

Volumn 149, Issue 3, 2000, Pages 306-312

  Dulawa, Stephanie C ^a   Scearce Levie, Kimberly A ^b   Hen, Rene ^c   Geyer, Mark A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GLADSTONE INSTITUTES   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

GR 127935; MBDB; MDMA; Sensorimotor gating; Serotonin 1B receptor; Startle

Indexed keywords

1 (1,3 BENZODIOXOL 5 YL) N METHYL 2 BUTANAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; SEROTONIN; SEROTONIN 1B RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; KNOCKOUT MOUSE; MOUSE; MOUSE STRAIN; NEUROPSYCHIATRY; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; STARTLE REFLEX;

3,4-METHYLENEDIOXYAMPHETAMINE; ANIMALS; MICE; MICE, KNOCKOUT; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; OXADIAZOLES; PIPERAZINES; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGENTS; SEROTONIN ANTAGONISTS; STARTLE REACTION;

EID: 0034073387     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000373     Document Type: Article

References (47)

1. Anderson G, Braun G, Braun U, Nichols D, Shulgin A (1978) Absolute configuration and psychomimetic activity. NIDA Res Monogr 22:8-15
2. 1B receptors in the developing somatosensory and visual cortices are located on thalamocortical axons. Proc Natl Acad Sci USA 90:153-157
3. Bolino F, Di Michele V, Di Cicco L, Manna V, Daneluzzo E, Casacchia M (1994) Sensorimotor gating and habituation evoked by electro-cutaneous stimulation in schizophrenia. Biol Psychiatry 36:670-679
4. 1B receptor is localized predominantly on axon terminals. Neuroscience 58:167-82
5. Braff DL, Stone C, Callaway E, Geyer MA, Glick I, Bali L (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15:339-343
6. Braff DL, Grillon C, Geyer MA (1992) Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49:206-215
7. Castellanos FX, Fine EJ, Kaysen D, Marsh WL, Rapoport JL, Hallet M (1996) Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results. Biol Psychiatry 39: 33-41
8. Davis M, Sollberger A (1971) Twenty-four hour periodicity of the startle response in rats. Psychon Sci 25:1
9. Dulawa SC, Geyer MA (1998) The effects of MDMA, RU24969, 8-OH-DPAT, and DOM on prepulse inhibition and startle habituation in three different mouse strains. Abstr Soc Neurosci 958
10. 1B knockout mice. Psychopharmacology 132:125-134
11. 1B knockout mice. Ann NY Acad Sci 861:79-84
12. 1B binding sites. Naunyn Schmiedeberg's Arch Pharmacol 332:1-7
13. Geyer MA, Callaway CW (1994) Behavioral pharmacology of ring-substituted amphetamine analogs. In: Cho AK, Segal DS (eds) Amphetamine and its analogs: psychopharmacology, toxicology, and abuse. Academic Press, San Diego, pp 177-208
14. Geyer MA, Swerdlow NR (1998) Measurement of startle response, prepulse inhibition, and habituation. In: Crawley JN, Skolnick P (eds) Current protocols in neuroscience, vol 2. Wiley, New York, pp 8.7.1-8.7.15
15. Glennon RA, Yousif M, Patrick G (1988) Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs. Pharmacol Biochem Behav 29:443-449
16. Grillon C, Ameli R, Charney DS, Krystal J, Braff DL (1992) Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol Psychiatry 32:939-943
17. 1D receptor subtypes. Trends Pharmacol Sci 17:103-105
18. Hekmatpanah CR, Peroutka SJ (1990) 5-Hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents. Eur J Pharmacol 177:95-98
19. Hen R (1992) Of mice and flies: commonalities among 5-HT receptors. Trends Pharmacol Sci 13:160-165
20. 1B receptor being a 5-HT autoreceptor. Pharmacol Toxicol 70:131-134
21. Johnson MP, Hoffman AJ, Nichols DE (1986) Effects of enantiomers of MDA, MDMA, and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices. Eur J Pharmacol 132:269-276
22. Johnson MP, Hanson GR, Gibb JW (1987) Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems in the rat. Biochem Pharmacol 36:4085-4093
23. Lucas JJ, Segu L, Hen R (1997) 5-Hydroxytryptamine1B receptors modulate the effect of cocaine on c-fos expression: converging evidence using 5-hydroxytryptamine1B knockout mice and the 5-hydroxytryptamine1B/1D antagonist GR 127935. Mol Pharmacol 51:755-763
24. Mansbach RS, Geyer MA, Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94:507-514
25. Meltzer HY (1995) The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist antipsychotics. J Clin Psychopharmacol 15:2S-3S
26. Meltzer H, Bastani B, Jayathilaki K, Maes M (1997) Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder. Neuropsychopharmacology 17:1-11
27. Middlemiss DN (1984) Stereoselective blockade by [3H]5-HT binding sites and at the 5-HT autoreceptor by propranolol. Eur J Pharmacol 101:289-293
28. Nichols DE (1986) Differences between the action of MDMA, MBDB and the classic hallucinogens. Identification of a new therapeutic class: entactogens. J Psychoactive Drugs 18:305-313
29. Nichols DE, Hoffman AJ, Oberlender RA, Jacob P, Shulgin AT (1986) Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class. J Med Chem 29:2009-2015
30. Oberlander R, Nichols DE (1988) Drug discrimination studies with MDMA and amphetamine. Psychopharmacology 95:71-76
31. Pazos A, Hoyer D, Dietl MM, Palacios JM (1988) Neuronal serotonin. Wiley, New York
32. Phillips TJ, Hen R, Crabbe JC (1999) Complications associated with genetic background effects in research using knockout mice. Psychopharmacology 147:5-7
33. Rocha BA, Scearce-Levie K, Lucas JJ, Hiroi N, Castanon N, Crabbe JC, Nestler EJ, Hen R (1998) Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature 393:175-178
34. Scearce K, Kassir S, Lucas J, Castanon N, Segu L, Arango V, Hen R (1997) Dopaminergic compensations in knockout mice lacking the serotonin 1B receptor. Abstr Soc Neurosci 202.2
35. Scearce-Levie K, Castanon N, Lucas JJ, Hiroi N, Rocha B, Nestler EJ, Segu L, Hen R (1998) 5-HT1B receptors modulate the effects of cocaine: comparison of genetic and pharmacological approaches. Abstr Soc Neurosci 861.10
36. Scearce-Levie K, Viswanathan SS, Hen R (1999) Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor. Psychopharmacology 141:154-161
37. Schmidt C (1987) Neurotoxicity of the psychedelic amphetamine, MDMA. J Pharmacol Exp Ther 240:1-7
38. Shulgin AT (1978) Psychotomimetic drugs: structure-activity relationships. In: Iverson LL, Iverson SD, Snyder SH (eds) Handbook of psychopharmacology, vol 11. Raven Press, New York, pp 243-333
39. Sipes TA, Geyer MA (1994) Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology 33:441-448
40. 1D receptors in the modulation of prepulse inhibition of startle. Psychopharmacology 125:231-237
41. Sipes TE, Geyer MA (1997) DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum. Brain Res 761:97-104
42. Stark KL, Oosting R, Hen R (1998) Novel strategies to probe the functions of serotonin receptors. Biol Psychiatry 44:163-168
43. Swerdlow NR, Braff DL, Geyer MA (1990) GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats. Brain Res 532:146-150
44. Swerdlow NR, Keith VA, Braff DL, Geyer MA (1991) The effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine-inhibition of sensorimotor gating of the startle response in the rat. J Pharmacol Exp Ther 256:530-536
45. Swerdlow NR, Benbow CH, Zisook S, Geyer MA, Braff DL (1993) A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol Psychiatry 33:298-301
46. Swerdlow NR, Paulsen J, Braff DL, Butters N, Geyer MA, Swenson MR (1995) Impaired prepulse inhibition of acoustic and tactile startle in patients with Huntington's Disease. J Neurol Neurosurg Psychiatry 58:192-200
47. Wu SY, Wang MY, Dun NJ (1991) Serotonin via presynaptic 5-HT1 receptors attenuates synaptic transmission to immature rat motorneurons in vitro. Brain Res 554:111-121